Lenvatinib is a medication used to treat specific types of cancer. Specifically, it is FDA-approved for the following:
- Radioactive iodine-refractory differentiated thyroid cancer (DTC)
- Unresectable or advanced hepatocellular carcinoma (HCC)
- Advanced renal cell carcinoma (RCC)
Therefore, lenvatinib is used to treat different types of cancers, primarily thyroid, liver, and kidney cancer, when other treatments are not effective or the cancer is advanced.